Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Total 13F shares
-
227,616,918
-
Share change
-
+5,507,775
-
Total reported value
-
$64,170,095,418
-
Put/Call ratio
-
82%
-
Price per share
-
$282.21
-
Number of holders
-
1,017
-
Value change
-
+$1,536,564,497
-
Number of buys
-
486
-
Number of sells
-
497
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2019
As of 30 Jun 2019,
Elevance Health, Inc. - Common Stock (ELV) was held by
1,017 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
227,616,918 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., Viking Global Investors LP, BAILLIE GIFFORD & CO, and BARROW HANLEY MEWHINNEY & STRAUSS LLC.
This page lists
1,018
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.